Cytokine removal under hemodiafiltration with endogenous reinfusion in acute kidney injury secondary to angioimmunoblastic T-cell lymphoma: a case report
- PMID: 23344085
- DOI: 10.1159/000346288
Cytokine removal under hemodiafiltration with endogenous reinfusion in acute kidney injury secondary to angioimmunoblastic T-cell lymphoma: a case report
Abstract
Angioimmunoblastic T-cell lymphoma shows a high release of cytokines. Different blood purification techniques are employed to control hypercytokinemia. Here we investigated the effects of intermittent supra-hemodiafiltration with endogenous reinfusion on cytokine removal in a patient presenting with acute kidney injury. After the first day of chemotherapy for angioimmunoblastic T-cell lymphoma, a 78-year-old male patient developed acute kidney injury and systemic inflammatory response syndrome due to massive release of inflammatory cytokines. Three sessions of supra-hemodiafiltration were performed. Blood samples for evaluation of renal function and inflammatory mediators were collected at the beginning and the end of each dialytic session. A marked improvement of clinical state and renal function was associated to a significant reduction of inflammatory markers. Our results suggest that renal replacement therapy with supra-hemodiafiltration may remove a wide spectrum of inflammatory mediators and uremic toxins involved in acute kidney injury and systemic inflammatory response syndrome.
Copyright © 2012 S. Karger AG, Basel.
Similar articles
-
Enhanced vascular endothelial growth factor and inflammatory cytokine removal with online hemodiafiltration over high-flux hemodialysis in sepsis-related acute kidney injury patients.Ther Apher Dial. 2013 Oct;17(5):557-63. doi: 10.1111/1744-9987.12016. Epub 2013 Feb 17. Ther Apher Dial. 2013. PMID: 24107284 Clinical Trial.
-
High-Dose Versus Conventional-Dose Continuous Venovenous Hemodiafiltration and Patient and Kidney Survival and Cytokine Removal in Sepsis-Associated Acute Kidney Injury: A Randomized Controlled Trial.Am J Kidney Dis. 2016 Oct;68(4):599-608. doi: 10.1053/j.ajkd.2016.02.049. Epub 2016 Apr 12. Am J Kidney Dis. 2016. PMID: 27084247 Clinical Trial.
-
Management of acute kidney injury in frail patients with biopsy-proven cast nephropathy: a combined approach with chemotherapy plus Supra-hemodiafiltration with post-adsorption endogenous reinfusion.J Nephrol. 2022 May;35(4):1243-1249. doi: 10.1007/s40620-021-01226-4. Epub 2022 Jan 4. J Nephrol. 2022. PMID: 34982413
-
A male with angioimmunoblastic T-cell lymphoma and proliferative glomerulonephritis.Ann Hematol. 2004 Jul;83(7):455-9. doi: 10.1007/s00277-003-0828-5. Epub 2004 Mar 18. Ann Hematol. 2004. PMID: 15034757 Review.
-
Renal cell therapy in the treatment of patients with acute and chronic renal failure.Blood Purif. 2004;22(1):60-72. doi: 10.1159/000074925. Blood Purif. 2004. PMID: 14732813 Review.
Cited by
-
Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data.Br J Haematol. 2015 Jul;170(1):96-109. doi: 10.1111/bjh.13400. Epub 2015 Apr 19. Br J Haematol. 2015. PMID: 25891346 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources